DEA Wants More Psychedelics for Research Purposes

The Drug Enforcement Administration (DEA) last week proposed increasing its 2024 production quotas for research-grade psychedelic compounds including psilocybin, psilocin, and ibogaine, according to a Lucid News report.

The revised production agenda, posted in a notice to the Federal Reserve, calls for increasing production of from 20,000 to 30,000 grams of psilocybin and from 24,000 to 36,000 grams of psilocin, a 50% overall increase. ...

Continue Reading →

DEA Calls To Increase Production of Psychedelics For Clinical Research

This week, the Drug Enforcement Administration (DEA) proposed increases to the production quotas of psilocybin, psilocin, and ibogaine for use by researchers investigating therapies with psychedelic compounds. The DEA oversees the regulated synthesis and cultivation of restricted psychoactive materials for scientific investigations.

A revised production agenda for 2024 calls for psilocybin and psilocin production to be increased by 50% – from 20,000 to 30,000 grams for psilocybin, and 24,000 to ...

Continue Reading →
Page 1 of 67 12345...»
UA-77446339-1